Galleri Cancer Screening Test
Early cancer detection for over 50 types of cancer
In-clinic Galleri blood draw at Next Health to screen for cancer signals across 50+ cancer types, with results in about two weeks
Collection
In-lab
Turnaround
Approximately 2 weeks after sample received at GRAIL lab
Price
$1,185
Physician reviewed
Yes
Membership
Not required
About
Galleri is a GRAIL multi-cancer early detection blood test offered through Next Health clinics. It screens for cancer signals across 50+ cancer types, including several cancers without standard screening programs, and can estimate the likely tissue of origin when a signal is found. Next Health's role is the in-clinic blood draw and provider setting around a test developed and processed by GRAIL.
Prescription required; results reviewed with healthcare provider to guide diagnostic next steps if a cancer signal is detected
What to Know
Signature approach
Galleri analyzes methylation patterns in cell-free DNA circulating in the blood. A detected signal does not diagnose cancer by itself; it gives the clinician a focused starting point for follow-up testing based on the predicted cancer signal origin.
What sets it apart
- Broad screening scope. Galleri looks across 50+ cancer types instead of one organ system at a time.
- Useful for unscreened cancers. The test includes many cancers that do not have routine recommended screening pathways.
- Clinic-based access. Through Next Health, the draw happens in person rather than as a self-directed order.
Before You Order
- Screening, not diagnosis. A positive signal needs follow-up diagnostic testing, and a negative result does not rule out every cancer. - Coverage is limited. Most insurance plans do not cover Galleri; HSA/FSA eligibility may depend on the administrator. - Price varies by channel. Next Health lists $1,185 while GRAIL lists a lower direct price and some providers may offer reduced pricing.
What's tested
Panel focus
What's included
Biomarker categories
Multi-Cancer Signal Detection (cfDNA methylation)
50 markersWhat’s not included
Does not diagnose cancer. Diagnostic testing is needed to confirm if cancer is present. Does not detect all cancers and not all cancers can be detected in the blood. False positive and false negative results occur. Should be used in addition to standard recommended cancer screenings.
Pricing
Starting at
$1,185
Blood draw at Next Health location, GRAIL lab analysis, cancer signal detection across 50+ types, Cancer Signal Origin prediction if signal detected
Panel details
Galleri Cancer Screening Test
In Lab
In-clinic blood draw, GRAIL cell-free DNA methylation analysis, cancer signal detection for 50+ cancer types, Cancer Signal Origin prediction
In practiceReal-world pricing notes, add-ons, and coverage limits.
Next Health lists Galleri at $1,185 GRAIL lists direct pricing at $949 and some healthcare providers offer it for $799 or less. Most insurance does not cover the test; GRAIL notes possible HSA/FSA eligibility, payment plans, and financial assistance for qualifying individuals.
How it works
- 1
Purchase the test
Order the Galleri Cancer Screening Test through Next Health for $1,185
- 2
Visit for blood draw
Go to a Next Health location for a simple in-clinic blood draw.
- 3
GRAIL lab analysis
Your blood sample is sent to GRAIL's lab for cell-free DNA methylation analysis, screening for signals from 50+ cancer types.
- 4
Receive results
Results are available approximately two weeks after the lab receives your sample. If a cancer signal is detected, the report identifies the most likely tissue of origin to guide next steps.
US availability
Availability
Not available in 1 US region
Available in all other US regions.
Exceptions
New York
Cannot ship to New York
Other tests from Next Health
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.